NasdaqGS - Delayed Quote • USD
Sabra Health Care REIT, Inc. (SBRA)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:20 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 7 | 7 | 7 | 7 |
Avg. Estimate | 0.14 | 0.14 | 0.58 | 0.64 |
Low Estimate | 0.13 | 0.13 | 0.54 | 0.58 |
High Estimate | 0.14 | 0.15 | 0.6 | 0.7 |
Year Ago EPS | -0.04 | 0.09 | 0.06 | 0.58 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 10 | 10 | 10 | 10 |
Avg. Estimate | 159.88M | 161.96M | 652.01M | 686.12M |
Low Estimate | 154.3M | 155.7M | 626.3M | 650.9M |
High Estimate | 166.7M | 169.02M | 684.21M | 741.44M |
Year Ago Sales | 159.1M | 161.17M | 647.52M | 652.01M |
Sales Growth (year/est) | 0.50% | 0.50% | 0.70% | 5.20% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 0.11 | 0.1 | 0.13 | 0.13 |
EPS Actual | -0.04 | 0.09 | -0.07 | 0.07 |
Difference | -0.15 | -0.01 | -0.2 | -0.06 |
Surprise % | -136.40% | -10.00% | -153.80% | -46.20% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.14 | 0.14 | 0.58 | 0.64 |
7 Days Ago | 0.14 | 0.14 | 0.58 | 0.64 |
30 Days Ago | 0.14 | 0.14 | 0.58 | 0.65 |
60 Days Ago | 0.14 | 0.15 | 0.6 | 0.65 |
90 Days Ago | 0.14 | 0.15 | 0.6 | 0.63 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | SBRA | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 450.00% | -- | -- | 1.60% |
Next Qtr. | 55.60% | -- | -- | 10.50% |
Current Year | 866.70% | -- | -- | 5.20% |
Next Year | 10.30% | -- | -- | 13.30% |
Next 5 Years (per annum) | 7.30% | -- | -- | 11.22% |
Past 5 Years (per annum) | -24.19% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Initiated | Deutsche Bank: Buy | 1/30/2024 |
Maintains | Mizuho: Buy to Buy | 1/3/2024 |
Maintains | Stifel: Buy to Buy | 11/7/2023 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 10/17/2023 |
Downgrade | BMO Capital: Outperform to Market Perform | 10/17/2023 |
Upgrade | Wells Fargo: Underweight to Equal-Weight | 10/16/2023 |
Related Tickers
OHI Omega Healthcare Investors, Inc.
30.42
+1.47%
HR Healthcare Realty Trust Incorporated
13.96
+1.23%
DOC Healthpeak Properties, Inc.
17.98
-0.17%
GMRE Global Medical REIT Inc.
8.19
+0.86%
NHI National Health Investors, Inc.
61.52
+1.79%
LTC LTC Properties, Inc.
31.80
+0.98%
VTR Ventas, Inc.
43.13
+1.15%
CTRE CareTrust REIT, Inc.
23.69
-0.21%
WELL Welltower Inc.
91.32
+0.56%
UHT Universal Health Realty Income Trust
33.45
+2.32%